An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease

BACKGROUND: Glucocorticoids (GCs) are first‐line treatment for keloid disease (KD) but are limited by high incidence of resistance, recurrence and undesirable side‐effects. Identifying patient responsiveness early could guide therapy. METHODS: Nineteen patients with KD were recruited at week 0 (befo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, D., Syed, F., Matthews, L.C., Ray, D.W., McGrouther, D.A., Watson, R.E.B., Bayat, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744777/
https://www.ncbi.nlm.nih.gov/pubmed/25712143
http://dx.doi.org/10.1111/bjd.13752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744777/
https://www.ncbi.nlm.nih.gov/pubmed/25712143
http://dx.doi.org/10.1111/bjd.13752

Ejemplares similares